MSB 3.21% $1.13 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-236

  1. 83 Posts.
    lightbulb Created with Sketch. 4
    "was that the same approval when CEO Alan Robertson sold 500,000 shares of company stock the day ahead of the vote to pay a tax bill".

    What are you talking about, please? When was this?

    Thanks!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.